“Inequalities in access to medicines for diabetes and hypertension across the capitals in different regions of Brazil: a population-based study”

• Main Authors: Vanessa Iribarrem Avena Miranda, Antônio Augusto Schäfer, Cristiane Damiani Tomasi, Jacks Soratto, Fernanda de Oliveira Meller, Marysabel Pinto Telis Silveira
• Format: Article
• Language: English
• Published: BMC 2021-06-01
• Series: BMC Public Health
• Subjects: Pharmaceutical services; Pharmacoepidemiology; Health inequalities; Cross-sectional studies; Diabetes; Hypertension
• Online Access: https://doi.org/10.1186/s12889-021-11279-6

Abstract Background To guarantee prevention and adequate treatment, as required for the population to have access to health services and technologies, including medicines. The purpose of this study is to analyse the economic and regional inequalities in access to medicines for diabetes and hypertension among the adult population in Brazil. Methods This was a cross-sectional study with adults aged 18 and over from the VIGITEL study conducted in 2019 in all Brazilian regions. Non-access to antidiabetic and antihypertensive drugs was assessed according to formal education and housing macro-region. The slope index of inequality (SII) was used to analyse absolute inequalities. Results The total number of individuals interviewed was 52,443. Approximately 10.0% of the people with diabetes and/or hypertension reported not having access to drug treatment. The major means for having access to antihypertensive drugs, in all regions, was private pharmacies; for antidiabetics, in the North region, people had greater access through private pharmacies, while in the Northeast, Southeast and South, they had greater access through the public sector. Inequalities were found in the lack of access to medicines according to the region of residence, especially in the North region. Conclusion The lack of access to medicines showed regional disparities, particularly in the most economically vulnerable regions.